Belinostat

TargetMol
Product Code: TAR-T1852
Supplier: TargetMol
CodeSizePrice
TAR-T1852-5mg5mg£102.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1852-10mg10mg£120.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1852-1mL1 mL * 10 mM (in DMSO)£125.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1852-25mg25mg£149.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1852-50mg50mg£189.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1852-100mg100mg£245.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1852-200mg200mg£349.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1852-500mg500mg£535.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Belinostat is a novel hydroxamic acid-type histone deacetylase (HDAC) inhibitor with antineoplastic activity. Belinostat targets HDAC enzymes, thereby inhibiting tumor cell proliferation, inducing apoptosis, promoting cellular differentiation, and inhibiting angiogenesis. This agent may sensitize drug-resistant tumor cells to other antineoplastic agents, possibly through a mechanism involving the down-regulation of thymidylate synthase.
CAS:
414864-00-9
Formula:
C15H14N2O4S
Molecular Weight:
318.35
Pathway:
DNA Damage/DNA Repair; Chromatin/Epigenetic
Purity:
0.9993
SMILES:
ONC(=O)C=Cc1cccc(c1)S(=O)(=O)Nc1ccccc1
Target:
HDAC

References

1. Plumb JA, et al. Mol Cancer Ther, 2003, 2(8), 721-728. 2. Buckley MT, et al. J Transl Med, 2007, 5:49. 3. Qian X, et al. Mol Cancer Ther, 2006, 5(8), 2086-2095. 4. Chowdhury S, et al. J Biol Chem, 2011, 286(35), 30937-30948. 5. Duan J, et al. Mol Cancer Ther, 2007, 6(1), 37-50. 6. Zuo Y, Xu H, Chen Z, et al. 17?AAG synergizes with Belinostat to exhibit a negative effect on the proliferation and invasion of MDA?MB?231 breast cancer cells[J]. Oncology Reports. 2020, 43(6): 1928-1944.